GB Patent

GB0116249D0 — Methods

Assigned to Ip2ipo Innovations Ltd · Expires 2001-08-29 · 25y expired

What this patent protects

Patent listed against Imbruvica.

Drugs covered by this patent

Patent Metadata

Patent number
GB0116249D0
Jurisdiction
GB
Classification
—
Expires
2001-08-29
Drug substance claim
No
Drug product claim
No
Assignee
Ip2ipo Innovations Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.